Botanix Pharmaceuticals Limited (ASX:BOT)
0.0350
-0.0020 (-5.41%)
Apr 20, 2026, 3:59 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 92.29 million as of April 20, 2026. Its market cap has decreased by -88.56% in one year.
Market Cap
92.29M
Enterprise Value
61.76M
Revenue
21.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 92.29M, an increase of 652.52%. That is a compound annual growth rate of 22.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 92.29M | -65.27% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 143.66M |
| Alterity Therapeutics | 108.75M |
| Island Pharmaceuticals | 106.41M |
| Immutep | 101.69M |
| Paradigm Biopharmaceuticals | 101.65M |
| Arovella Therapeutics | 97.91M |
| Cynata Therapeutics | 85.48M |
| Amplia Therapeutics | 84.66M |